Mind the gap in kidney care: Translating what we know into what we do

Valerie A Luyckx1, Katherine R Tuttle2, Dina Abdellatif3

  • 1Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland; Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa.

Nefrologia
|November 15, 2024
PubMed

Insights

Bridging the gap between kidney disease knowledge and practice is crucial. Early diagnosis and treatment, despite existing guidelines for risk factors like hypertension and diabetes, are significantly delayed due to numerous barriers.

Area of Science:

  • Nephrology
  • Public Health
  • Healthcare Management

Background:

  • Significant delay exists in translating kidney disease treatments from clinical evidence to practice.
  • Effective interventions to prevent or slow kidney disease are underutilized.
  • Many individuals with risk factors (hypertension, diabetes) or kidney disease itself remain undiagnosed or undertreated.

Purpose of the Study:

  • To highlight the critical need to accelerate the implementation of evidence-based kidney disease treatments.
  • To identify and address systemic barriers hindering early diagnosis and appropriate management of kidney disease.
  • To emphasize the importance of primary care in maximizing opportunities for early kidney disease intervention.

Main Methods:

  • The study reviews existing guidelines for managing common kidney disease risk factors.
  • It analyzes the current state of diagnosis and treatment for kidney disease globally.
  • Barriers to care are examined across patient, clinician, health system, and societal levels.

Main Results:

  • A substantial gap persists between established kidney disease knowledge and clinical practice.
  • Early stages of kidney disease are often asymptomatic, leading to delayed diagnosis.
  • Despite available treatments, a small fraction of at-risk individuals receive timely diagnosis and optimal care.

Conclusions:

  • Urgent action is required to narrow the gap between kidney disease knowledge and practice.
  • Overcoming systematic barriers at all levels is essential for improving kidney health outcomes.
  • Maximizing early diagnosis and treatment, particularly at the primary care level, is imperative to prevent severe consequences.

Related Concept Videos

Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
269
Internal Anatomy of the Kidney01:12

Internal Anatomy of the Kidney

The kidneys are essential organs in the human body, performing a myriad of tasks that maintain homeostasis and overall health.
Anatomical Position and Dimensions
The kidneys are retroperitoneal organs positioned against the posterior abdominal wall on either side of the spine, roughly between the twelfth thoracic and third lumbar vertebrae. Each kidney is typically 10-12 cm long, 5-6 cm wide, and 3-4 cm thick, weighing about 150 grams.
Renal Cortex
The outermost region of the kidney is the...
1.3K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
144